The circulating sEV population from these patients was isolated by size exclusion chromatography, followed by analysis of EpCAM expression by flow cytometry (Figure 10A) and enrichment of breast cancer–derived sEVs using EpCAM+ beads (Figure 10B). This evidence concerns the gene EPCAM and breast carcinoma.